Leading the Way in Life Science Technologies

GEN Exclusives

More »

Companies

More »

Updated: Dec 9 2011

Molecular Targeting Technologies

  • Molecular Targeting Technologies
  • 833 Lincoln Avenue
  • Unit #9
  • West Chester, PA, 19380
  • UNITED STATES

Molecular Targeting Technologies, Inc. (MTTI) is a privately-held biotechnology company focused on the development of diagnostic and therapeutic molecules for cancer and infection.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »